| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | May 13, 2024 | Shemesh Shay Chief Dev. Ops. Officer | Buy | Nuvectis Pharma, Inc. | NVCT | $6.32 | $7,034 | +0.07% |
| Mar 21, 2023 | Mar 22, 2023 | Shemesh Shay Chief Dev. Ops. Officer | Buy | Nuvectis Pharma, Inc. | NVCT | $11.99 | $5,036 | +0.03% |
| Mar 15, 2023 | Mar 17, 2023 | Shemesh Shay Chief Dev. Ops. Officer | Buy | Nuvectis Pharma, Inc. | NVCT | $10.71 | $7,176 | +0.05% |
| Nov 16, 2022 | Nov 18, 2022 | Shemesh Shay Chief Dev. Ops. Officer | Buy | Nuvectis Pharma, Inc. | NVCT | $7.15 | $2,145 | +0.02% |
| Sep 23, 2022 | Sep 27, 2022 | Shemesh Shay Chief Dev. Ops. Officer | Buy | Nuvectis Pharma, Inc. | NVCT | $7.87 | $1,731 | +0.02% |
| Sep 02, 2022 | Sep 06, 2022 | Shemesh Shay Chief Dev. Ops. Officer | Buy | Nuvectis Pharma, Inc. | NVCT | $8.31 | $3,357 | +0.03% |
| Aug 31, 2022 | Sep 02, 2022 | Shemesh Shay Chief Dev. Ops. Officer | Buy | Nuvectis Pharma, Inc. | NVCT | $8.07 | $24,258 | +0.24% |
| May 20, 2022 | May 23, 2022 | Shemesh Shay Chief Dev. Ops. Officer | Buy | Nuvectis Pharma, Inc. | NVCT | $16.54 | $4,962 | +0.02% |
| May 16, 2022 | May 18, 2022 | Shemesh Shay Chief Dev. Ops. Officer | Buy | Nuvectis Pharma, Inc. | NVCT | $19.44 | $4,704 | +0.02% |
| May 12, 2022 | May 13, 2022 | Shemesh Shay Chief Dev. Ops. Officer | Buy | Nuvectis Pharma, Inc. | NVCT | $15.85 | $20,255 | +0.10% |
| Feb 04, 2022 | Feb 08, 2022 | Shemesh Shay Chief Development Officer | Buy | Nuvectis Pharma, Inc. | NVCT | $3.41 | $10,034 | +0.25% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.